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Abstract
Introduction
Between 1998 and 2010, S. Typhi was an uncommon cause of bloodstream infection (BSI)
in Blantyre, Malawi and it was usually susceptible to first-line antimicrobial therapy. In 2011
an increase in a multidrug resistant (MDR) strain was detected through routine bacteriologi-
cal surveillance conducted at Queen Elizabeth Central Hospital (QECH).
Methods
Longitudinal trends in culture-confirmed Typhoid admissions at QECH were described be-
tween 1998–2014. A retrospective review of patient cases notes was conducted, focusing
on clinical presentation, prevalence of HIV and case-fatality. Isolates of S. Typhi were se-
quenced and the phylogeny of Typhoid in Blantyre was reconstructed and placed in a
global context.
Results
Between 1998–2010, there were a mean of 14 microbiological diagnoses of Typhoid/year
at QECH, of which 6.8% were MDR. This increased to 67 in 2011 and 782 in 2014 at which
time 97% were MDR. The disease predominantly affected children and young adults (medi-
an age 11 [IQR 6-21] in 2014). The prevalence of HIV in adult patients was 16.7% [8/48],
similar to that of the general population (17.8%). Overall, the case fatality rate was 2.5%
(3/94). Complications included anaemia, myocarditis, pneumonia and intestinal perforation.
112 isolates were sequenced and the phylogeny demonstrated the introduction and clonal
expansion of the H58 lineage of S. Typhi.
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Conclusions
Since 2011, there has been a rapid increase in the incidence of multidrug resistant, H58-
lineage Typhoid in Blantyre. This is one of a number of reports of the re-emergence of Ty-
phoid in Southern and Eastern Africa. There is an urgent need to understand the reservoirs
and transmission of disease and how to arrest this regional increase.
Author Summary
Typhoid fever is a major cause of disease and death around the world, particularly in re-
source limited settings, although reports suggest that until recently it has been much less
prominent in sub-Saharan Africa (SSA) than Asia. Estimates of the precise burden of this
disease are, however, difficult, as diagnosis requires advanced laboratory diagnostics. This
is a particular problem in much of SSA where long-term laboratory surveillance has been
available in just a few settings. Queen Elizabeth Central Hospital (QECH), Blantyre, Ma-
lawi is one such setting; between 1998 and 2010, cases of Typhoid fever at QECH were
both uncommon and responsive to all antibiotics. In 2011 a marked increase in highly an-
tibiotic resistant Typhoid fever began, with 843 confirmed cases in 2013. A review of cases
revealed that one in 40 patients died and one in five had complicated disease. A further
study of the DNA of bacteria associated with the outbreak revealed a novel strain, common
to Asia, has arrived in Malawi. This is one of a number of reports of the re-emergence of
Typhoid fever in Southern and Eastern Africa. There is an urgent need to understand the
reservoirs and transmission of disease and how to arrest this regional increase.
Introduction
Typhoid fever, caused by Salmonella enterica serovar Typhi remains one of the most important
infectious diseases globally, responsible for an estimated 26.9 million infections and 269,000
deaths in 2010 [1]. The accuracy of this estimate in sub-Saharan Africa (SSA) is limited by the
paucity of diagnostic microbiological facilities in this setting, and the non-specific nature of Ty-
phoid fever, which typically presents with non-focal sepsis, making syndromic diagnosis unre-
liable [2]. It has been suggested that the burden of Typhoid fever in Africa before 2010 has
been over-estimated [3].
Whilst Typhoid has remained a major public health problem in Asia, there have been nu-
merous reports consistently showing that nontyphoidal serovars of Salmonella (NTS) are a
more prominent cause of bloodstream infection (BSI) in sub-Saharan Africa (SSA) [4]. In Blan-
tyre, Malawi, there have been two well-documented epidemics of BSI caused by multidrug re-
sistant (MDR) NTS serovars since 1998, while S. Typhi, until recently, has represented only 1%
of Salmonella BSI [5].
The sequential acquisition of antimicrobial resistance (AMR) genes has been a prominent
feature of Typhoid fever in Asia. MDR to amoxicillin, chloramphenicol and cotrimoxazole has
been common since the 1980s [6]. This phenotype was largely associated with an IncH1 plas-
mid [7] and the use of any of these drugs will act to maintain this plasmid. This phenotype has
led to the widespread use of fluoroquinolones in the management of Typhoid fever in Asia, the
emergence and spread of diminished ciprofloxacin susceptibility and the increasing use of
3rd-generation cephalosporins and azithromycin there [8]. AMR surveillance data from SSA
are sparse.
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The Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW) has con-
ducted longitudinal surveillance of BSI in adult and paediatric medical patients presenting to
Queen Elizabeth Central Hospital (QECH) with clinically suspected severe bacterial infection
since 1998. In 2011 we detected an increase in microbiologically confirmed S. Typhi and here
we report the emergence of a rapid and sustained increase in MDR Typhoid fever.
Methods
Setting
QECH is the largest government hospital in Malawi with 1,300 beds and provides free health-
care to Blantyre district (population approximately 1.3 million) and tertiary care to the South-
ern region of Malawi. MLW has conducted routine BSI surveillance since 1998 [9], obtaining
blood for culture from all adult patients (age16) admitted to the medical wards with an axil-
lary temperature over 37.5°C or with clinical suspicion of sepsis. In addition, blood cultures
were obtained from febrile children (age<16) that were malaria slide negative or positive and
critically ill, or from afebrile children with clinical suspicion of sepsis. Aerobic blood cultures
were taken under aseptic conditions and before the administration of antibiotics. Sampling cri-
teria did not change between 1998–2014.
Microbiological methods
Automated blood culture has been undertaken at MLW using a standard aerobic bottle (BacT/
Alert, bioMérieux Marcy-L'Etoile, France) since 2000, although prior to this, manual culture
was undertaken [9]. The sample date, patient details (name, age and gender), blood culture re-
sult and antimicrobial susceptibility profile of any pathogen isolated were recorded. All isolates
were identified using standard diagnostic techniques [10]. Salmonellae were identified by bio-
chemical profile using API20E (bioMérieux Marcy-L'Etoile, France) and serotyped according
to the White-Kauffmann-Le Minor scheme by antisera (Pro-Lab Diagnostics, UK) [11]. Coag-
ulase-negative staphylococci, Bacillus spp., diptheroids and alpha-haemolytic streptococci
other than S. pneumoniae (when there was no clinical suspicion of endocarditis) were consid-
ered as contaminants. MLW audits blood culture volumes and contamination rates [12].
Antimicrobial susceptibility testing was performed by disc diffusion using ampicillin, chlor-
amphenicol, cotrimoxazole, cefpodoxime and ciprofloxacin discs according to British Society of
Antimicrobial Chemotherapy methods and breakpoints, and isolates that were found to be re-
sistant to ciprofloxacin or ceftriaxone by disc testing had e-tests (E-test macromethod, bioMér-
ieux Marcy-L'Etoile, France) performed. Diminished ciprofloxacin susceptibility (DCS) was
classified on the basis of a minimum inhibitory concentration (MIC) between 0.06–1 mg/L)
[13]. Isolates were described as “fully susceptible” if susceptible to these five antimicrobials.
MLW subscribes to the United KingdomNational External Quality Assessment Service (UK
NEQAS) scheme. Isolates deemed clinically significant were frozen on beads at -80°C. Prior to
October 2010, these data were entered into ledgers then double-entered into a validated data-
base. Since then they have been directly entered into an electronic laboratory information man-
agement system (LIMS).
Clinical management and data
Once the rapid increase in S. Typhi had been identified, a retrospective case note review of
adults (aged 16 years) identified by Salmonella disease surveillance (College of Medicine Re-
search Ethics Committee P.07/09/808) in the first 2 years of the increase (June 2011- June
2013) was undertaken. Clinical presentation, including focus of infection, HIV status (when
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known) and case-fatality rate at discharge were recorded. Data on survival at discharge
amongst paediatric patients during the first 12 months of the increase was collected from the
paediatric admissions ledgers. HIV testing was performed according to the Malawi national
HIV rapid antibody testing protocol, using Determine (Alere, USA) HIV-1/2 tests as the first
test in a serial testing algorithm. All positive test results were confirmed by Uni-Gold (Trinity
Biotech, USA). First line treatment for uncomplicated Typhoid fever at QECH was oral cipro-
floxacin for 7 days, at a dose of 750mg twice daily (bd) in adults and 20mg/kg bd (maximum
750mg) bd in children.
Minimum incidence
Minimum incidence of Typhoid fever/100,000 patients/year was calculated using an estimated
sensitivity of blood culture for the diagnosis of S. Typhi of 50%, therefore the number of positive
blood cultures recorded in each year was doubled to provide a numerator. QECH serves the
population of urban Blantyre, and the population size of Blantyre was estimated in the 1998 and
2008 census and population projections following the 2008 census have been published (Nation-
al Statistics Office, Malawi: www.nsomalawi.mw/2008-population-and-housing-census.html).
These numbers were used to provide a denominator.
Genomic characterization of S. Typhi in Blantyre
In order to investigate whether this increase represented clonal expansion of a single lineage of
S. Typhi, and to describe the full diversity of S. Typhi in Blantyre, blood culture isolates over
the course of the surveillance period were selected for whole genome sequencing to represent
the spectrum of antimicrobial susceptibility patterns in each year. These isolates were placed in
a global context using previously sequenced S. Typhi isolates of known haplotype [14,15]. One
S. Paratyphi (A270, Accession Number ERS223417) isolate was used as an out-group, to root
the tree.
DNA extraction for whole genome sequencing was conducted on the Qiagen Universal
Biorobot1 (Limburg, Netherlands) using Qiagen All-for-one1 extraction kits. Following DNA
extraction, PCR libraries were prepared from 500ng of DNA as previously described [16]. Iso-
lates were sequenced using Illumina HiSeq2500 machines (Illumina, San Diego, CA, USA) and
150 bp paired-end reads were generated.
Phylogeny was based on single nucleotide polymorphisms (SNPs) in conserved regions of
the genome; WGS data for each of isolates was mapped to the reference S. Typhi CT18 [7]
using SMALT (http://www.sanger.ac.uk/resources/software/smalt/: version 0.5.8). Phylogenet-
ic modelling is based on the assumption of a single common ancestor, therefore variable re-
gions, where horizontal genetic transfer occurs and repetitive regions, were excluded [15] [17].
A maximum likelihood phylogenetic tree was then built from the SNP alignments of the iso-
lates using RAxML (version 7.0.4) [18]. The maximum-likelihood phylogeny was supported by
100 bootstrap pseudo-replicate analyses of the alignment data. The presence of plasmids was
investigated using PlasmidFinder (Danish Technical University, Denmark: http://cge.cbs.dtu.
dk/services/PlasmidFinder/).
Ethics statement
Institutional approval for this study was obtained from the University of Malawi College of
Medicine Research Ethics Committee (COMREC). All data analyzed were anonymised.
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Results
Between 1998–2010, there were 176 microbiologically confirmed cases of S. Typhi at QECH in
Blantyre, a mean of 14/year (Table 1); 12/176 (6.8%) were multidrug resistant (MDR) to ampicil-
lin, chloramphenicol and cotrimoxazole and 147/176 (83.5%) were susceptible to all these com-
monly used antibiotics. All 176 were susceptible to both ciprofloxacin and ceftriaxone. A rapid
increase in isolation of S. Typhi began in Blantyre in 2011, with 67 cases that year, 186 in 2012,
843 in 2013 and 782 in 2014. Although the total number of blood cultures taken has varied, the
proportion of blood cultures yielding S. Typhi has risen from a long-term trend of0.3% before
2011 to 5.7% of all blood cultures in 2014. The minimum incidence of Typhoid fever for urban
Blantyre was estimated at 9.1/100,000 in 1998 and was stable until 2010 (1.4–9.1), but rose to
23.4/100.000 in 2011 and was 184/100,000 in 2014. A seasonal pattern has become apparent,
with peaks of cases towards the end of the wet season and early in the dry season, when the
prevalence of malnutrition is also highest (Fig 1).
In 2014, 754/782 (97%) were MDR. One isolate with phenotypic DCS was detected in 2011
(MIC 0.064mg/l), but none with outright ciprofloxacin resistance or ceftriaxone resistance
have been detected as yet. There was greatest diversity of antimicrobial resistance patterns in
2010 and 2011 (Table 2); in 2010, the year before the increase began, 6/18 (33.3%) isolates were
MDR and in 2011 42/67 (63.8%) were MDR (Table 3). To address the possibility that a greater
diversity of strains was circulating in these years, isolates from these years were sampled most
heavily for whole genome sequencing.
Age distribution
As is usual with Typhoid [6], the burden has fallen most heavily on children and young adults,
with the majority of cases in children aged<16 years (1075/1693 [63%]). The age distribution
Table 1. Temporal trends in S. Typhi isolation and antimicrobial resistance at QECH, Blantyre 1998–2013.
Year Number of S.
Typhi isolated
Number
MDR*
Proportion
MDR (%)
Number of Blood
cultures
Proportion of blood cultures
positive for S. Typhi
Estimated minimum incidence
Typhoid fever/100,000
1998 24 0 0 8545 0.3 9.1
1999 13 0 0 7823 0.2 4.9
2000 5 0 0 8052 0.1 1.9
2001 4 2 50 7653 0.1 1.4
2002 4 0 0 8978 0.0 1.4
2003 9 0 0 11174 0.1 3.1
2004 17 0 0 10653 0.2 5.7
2005 19 0 0 12933 0.1 6.2
2006 18 0 0 10123 0.2 5.7
2007 10 4 40 9167 0.1 3.1
2008 16 0 0 8628 0.2 4.8
2009 19 0 0 7991 0.2 5.5
2010 18 6 33 8507 0.2 5.0
2011 67 42 63 9890 0.7 23.4
2012 186 168 90 10433 1.8 47.5
2013 843 823 98 12815 6.6 206.6
2014 782 754 97 13663 5.7 184.1
*MDR: Multidrug resistant to amoxicillin, chloramphenicol, cotrimoxazole
doi:10.1371/journal.pntd.0003748.t001
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since 2011 is depicted in Fig 2A. Of note, the median age (Fig 2B) has fallen from 14 (IQR
8–24) in 2012 to 12 (IQR 6–20) in 2014 (p = 0.01), as the increase stabilized.
Retrospective case note review
A retrospective review of 77 adult admissions from the first 2 years of the increase was under-
taken. 73/77 had typical presentations, consisting of fever without focus, or one or more of
Fig 1. Monthly trends in bloodstream invasive Salmonella diagnosed at QECH fromNovember 2010-October 2014.
doi:10.1371/journal.pntd.0003748.g001
Table 2. Diversity of antimicrobial resistance phenotypes (n,%) amongst S. Typhi isolates from QECH, Blantyre 2010–2014.
2010 2011 2012 2013 2014 Total
Fully susceptible† 8 (44.4) 18 (26.9) 11 (5.9) 11 (1.3) 15 (1.9) 63 (3.3)
Cotrimoxazole 2 (11.1) 1 (1.5) 1 (0.5) 2 (0.2) 1 (0.1) 7 (0.4)
Chloramphenicol 0 (0.0) 2 (3.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.1)
Amoxicillin 0 (0.0) 2 (3.0) 1 (0.5) 1 (0.1) 1 (0.1) 5 (0.3)
Cotrimoxazole & Chloramphenicol 0 (0.0) 0 (0.0) 1 (0.5) 1 (0.1) 0 (0.0) 2 (0.1)
Amoxicillin & Cotrimoxazole 1 (5.6) 0 (0.0) 3 (1.6) 5 (0.6) 7 (0.9) 16 (0.8)
Amoxicillin & Chloramphenicol 0 (0.0) 1 (1.5) 0 (0.0) 1 (0.1) 2 (0.3) 4 (0.2)
MDR* 6 (33.3) 42 (62.7) 168 (90.3) 823 (97.6) 754 (96.4) 1793 (94.7)
Ciproﬂoxacin 0 (0.0) 1 (1.5) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.1)
Ceftriaxone 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Total 18 67 186 843 782 1893
† Susceptible to amoxicillin, chloramphenicol, cotrimoxazole, ciproﬂoxacin, ceftriaxone.
*MDR: Multidrug resistant to amoxicillin, chloramphenicol, cotrimoxazole
doi:10.1371/journal.pntd.0003748.t002
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headache, severe sepsis or gastrointestinal symptoms. Although 5/77 (6.5%) were confused,
none had any focal neurological syndromes similar to those reported in the outbreak in Neno,
Malawi [19]. Only 1 patient (1.3%) had intestinal perforation. HIV status was known in 48
cases; 8/48 (16.7%) were HIV infected, which is comparable with the prevalence for the general
population of Blantyre (17.8%), but is lower than for febrile adult admissions to QECH where
90% are HIV reactive [20]. 3/73 (4.2%) adult patients died.
A review of 330 paediatric admissions since the increase revealed 7 (2.1%) deaths. 212/248
(85.5%) children for whom fuller clinical details were available had a typical presentation with
non-focal sepsis and a further 52/248 (21.0%) had disease complicated by one of the following;
anaemia requiring transfusion (16 [6.5%]), meningism or decreased conscious level (13 [5.2%]),
pneumonia (12/248 [4.8%]), intestinal perforation/peritonitis (9/248 [3.6%]), hepatitis (1/248
[0.4%]) and myocarditis (1/248 [0.4%]). All 7 deaths occurred in the group of patients present-
ing with complex disease including 4/9 intestinal perforation/peritonitis and the one patient
with myocarditis. There were no cases of focal neurology or cranial nerve lesions [21]. HIV data
were not available but the paediatric inpatient seroprevelence obtained through routine testing
during this time was 13.6%.
Table 3. Phenotypic antimicrobial resistance patterns (n,%) of different clades.
Clade/Haplotype 1/H55 2/H50 3/H42 4/H52 5/H58
Fully susceptible† 6 (60.0) 3 (75.0) 0 (0.0) 10 (76.9) 6 (7.7)
Cotrimoxazole 0 (0.0) 0 (0.0) 0 (0.0) 2 (15.4) 0 (0.0)
Chloramphenicol 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Amoxicillin 0 (0.0) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0)
Cotrimoxazole & Chloramphenicol 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Amoxicillin & Cotrimoxazole 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 3 (3.8)
Amoxicillin & Chloramphenicol 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
MDR*number (%) 4 (40.0) 1 (25.0) 0 1 (7.7) 69 (88.4)
Total 10 4 1 15 78
† Susceptible to amoxicillin, chloramphenicol, cotrimoxazole, ciproﬂoxacin, ceftriaxone.
*MDR: Multidrug resistant to amoxicillin, chloramphenicol, cotrimoxazole
doi:10.1371/journal.pntd.0003748.t003
Fig 2. Age distribution of Typhoid in Blantyre 2011–14. 2A reflects the total age distribution frequency and 2B reflects the median age each year with
interquartile range.
doi:10.1371/journal.pntd.0003748.g002
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Overall, the case fatality rate from culture confirmed Typhoid fever in adult and paediatric
admissions to QECH following the increase in Typhoid fever was 2.5%.
Clonal expansion of H58 S. Typhi
112 S. Typhi isolates from 2004–2013 were selected for whole genome sequencing to give the
maximum temporal and antimicrobial susceptibility diversity of S. Typhi isolates contained
within the MLW strain collection (see S1 Table for accession numbers). The years 2010 (18 iso-
lates) and 2011 (67 isolates) showed greatest diversity of antimicrobial resistance profiles and a
rise in the proportion which displayed the MDR phenotype, suggesting that these were the
years in which a novel clade or clades were most likely to have become prominent in Blantyre.
Proportionately more isolates were therefore sequenced from these years.
Maximum likelihood phylogeny of the 112 isolates placed in the context of a collection of S.
Typhi isolates previously characterised by haplotyping revealed that five clades of S. Typhi were
isolated from patients presenting to QECH, but that the recent increase was dominated by one
clade, previously described as the “H58-haplotype”(Fig 3)[14]. H58 was first observed in this
collection of isolates in 2009 (Fig 4), although this isolate was on a different branch to the
Fig 3. Maximum-likelihood tree of 112 isolates of S.Typhi fromMalawi, placed in the context of 24 isolates representative of the global diversity of
S. Typhi and highlighting the previous diversity of Typhi isolates and the recent clonal expansion of the H58 haplotype. The left column depicts
lineage, the right column depicts time category. Scale bar reveals indicates substitutions/variable site.
doi:10.1371/journal.pntd.0003748.g003
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majority of the rest of the H58 isolates. It suggests that, prior to 2011, the sporadic Typhoid di-
agnosed in Blantyre was caused by a diversity of S. Typhi clades, but that the H58-haplotype
rapidly expanded in 2011. In this study, the H58 haplotype was much more strongly associated
with MDR (89.3%) than the other types of S. Typhi circulating (21.4%). Plasmid finder and in-
silico PCR were used to investigate the accessory genome of the H58 S. Typhi isolates. Both sug-
gested that the IncH1 plasmid was not present in any of the H58-isolates. Review of the chromo-
somes of these isolates revealed that the MDR region carried on an IncH1 plasmid by reference
strain CT18 has integrated into the chromosome of these isolates on a Tn21-like element be-
tween genes cyaA and cyaY. This has been observed previously in a Zambian epidemic [22].
Discussion
Seventeen years of longitudinal surveillance data demonstrate that S. Typhi was an uncommon
cause of BSI in adults and children in Blantyre, Malawi prior to 2011, and that an increase of
MDR Typhoid fever, initially involving a wide range of clades but subsequently dominated by
the H58-lineage began in 2011. This increase has now stabilized, but shows no sign of abating.
This finding is consistent with a number of recent reports from Eastern and Southern Africa of
outbreaks of Typhoid [21,23,24], which poses the questions, why is Typhoid emerging in
Southern and Eastern Africa and how can it be controlled?
The rapid emergence of the H58-lineage of S. Typhi is likely to be associated with its spec-
trum of antimicrobial resistance. Chloramphenicol and amoxicillin are widely available in the
community in Blantyre district and cotrimoxazole prophylaxis therapy is used as part of the
ARV-programme. This clade is associated with resistance to all three agents and the wide-
spread and poorly regulated use of these antimicrobials is likely to maintain this phenotype.
Fig 4. Proportion of sequenced S.Typhi isolates fromMLW collection belonging to each haplotype,
the number above each bar represents the total number sequenced for each year.
doi:10.1371/journal.pntd.0003748.g004
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Although S. Typhi and NTS appear to cause BSI in different patient groups, all 3 outbreaks of
invasive Salmonella disease in Blantyre have shared this resistance pattern [5]. In contrast,
DCS is a common feature of H58-S. Typhi in South Asia, therefore it is notable that DCS has
yet to be reported in Blantyre. It is also important to note that since the increase, Typhoid fever
has been associated with significant mortality and with complicated disease causing morbidity,
despite the availability of fluoroquinolones for treatment, which have been available for treat-
ment at QECH since 2002.
There have been two previously documented discrete epidemics of iNTS disease in Blantyre,
the first caused by Salmonella Enteritidis (1999–2002), and the second by S. Typhimurium
(2003–2010). iNTS disease has been associated with malaria, malnutrition and HIV [25],
whereas malaria does not appear to be a risk factor for Typhoid [26] and HIV may be protec-
tive against Typhoid [27]. In Blantyre, there has been a rapid and successful rollout of antire-
troviral therapy, including an increasingly effective prevention of mother to child transmission
programme [20]. Whilst this study does not provide evidence that HIV is protective against
Typhoid fever, there is no suggestion that it is a predisposing factor as is the case for NTS.
There has also been an expansion of malaria control interventions. Both of these interventions
are predicted to reduce the proportion of the population that is susceptible to iNTS disease. It
is also possible that the previous S. Enteritidis epidemic, which like S. Typhi is a member of Sal-
monella serogroup D, led to heterotypic immunity to Typhoid fever in the population of Blan-
tyre, which 10 years after the end of the epidemic is now in decline and this possibility should
be explored further. However, it is also possible that the arrival of the H58 MDR-associated
haplotype that has been broadly reported in Asia and locally in Africa has in itself been a driv-
ing factor in this rapid increase in disease. Again, further work is required to determine this.
Typhoid control has previously been associated with improvements in drinking- water qual-
ity, sanitation and hygiene practices [6,28–30]. This outbreak has occurred following an in-
crease in improved water source coverage in Malawi, however there are reports that many of
these water sources may have become contaminated and river water pollution in the city has
become a problem [31]. Use of inadequately treated sewage water and human faecal manure
from ecological sanitation latrines for growing vegetables must also be considered as potential
contributors to this increase [32]. A recent survey of the residents of informal settlements in
Blantyre found that only 7% of respondents practiced hand hygiene after defecation [33].
These pressures have been compounded by a dramatic increase in population growth; the pop-
ulation of Malawi has been growing at an estimated 2.8%/year based on national census projec-
tions, and Malawi is also urbanizing at the rate of 3% p.a. [34]. These increases in urban
population density without proportionate improvement in access to water and sanitary facili-
ties may have played a role in facilitating this outbreak.
We report microbiological data from a single center in Blantyre, however QECH is the sole
free-of-charge hospital in Blantyre, and this finding is likely to be generalizable to the rest of
urban Malawi. The clinical data are retrospective, based on available case-notes. Although the
DCS phenotype was not detected, the isolates were not tested against nalidixic acid, which is the
most sensitive method of detecting emerging DCS by disc testing [35]. It was only possible to se-
quence a selection of isolates from the MLW archive and we have sampled fewer isolates from
low-incidence years, so we cannot be sure precisely when H58-S. Typhi first arrived in Blantyre.
There has been rapid emergence of Typhoid in Blantyre not associated with HIV infection,
initially involving a wide range of clades, but dominated by the MDR H58-lineage of S. Typhi.
This is one of an increasing number of reports of outbreaks of Typhoid ever from the region.
There is a critical need for a comprehensive description of the clinical and molecular epidemi-
ology of this neglected tropical disease across Africa, in order to understand its true burden, to
model its transmission dynamics and to inform vaccination trials.
Epidemic Multidrug Resistant H58-S. Typhi in Malawi
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003748 April 24, 2015 10 / 13
Supporting Information
S1 Table. Isolates sequenced and their related accession numbers.
(CSV)
Acknowledgments
We would like to thank the staff and patients of QECH for their participation in this study. We
would like to thank Dr Storn Kabuluzi of the Malawian Ministry of Health for reviewing
the manuscript.
Author Contributions
Conceived and designed the experiments: NAF MAG RSH GD JP NK. Performed the experi-
ments: NAF KG VWAB JONMDZ PAN CMGS. Analyzed the data: NAF KG VWAB JON
MDZ PAN. Contributed reagents/materials/analysis tools: TJA JM GD JP RSH. Wrote the
paper: NAF KG VW CMGS SK TJA JM NK AB JON PANMDZ JP GDMAG RSH.
References
1. Buckle GC, Walker CL, Black RE. Typhoid fever and paratyphoid fever: Systematic review to estimate
global morbidity and mortality for 2010. J Glob Health. 2012; 2(1):010401. Epub 2012/12/01. doi: 10.
7189/jogh.02.010401 PMID: 23198130; PubMed Central PMCID: PMC3484760.
2. Peters RP, Zijlstra EE, Schijffelen MJ, Walsh AL, Joaki G, Kumwenda JJ, et al. A prospective study of
bloodstream infections as cause of fever in Malawi: clinical predictors and implications for manage-
ment. Trop Med Int Health. 2004; 9(8):928–34. Epub 2004/08/12. doi: 10.1111/j.1365-
3156.2004.01288.xTMI1288 [pii]. PMID: 15304000.
3. Mweu E, English M. Typhoid fever in children in Africa. Trop Med Int Health. 2008; 13(4):532–40. Epub
2008/03/04. doi: TMI2031 [pii] 10.1111/j.1365-3156.2008.02031.x. PMID: 18312473; PubMed Central
PMCID: PMC2660514. doi: 10.1111/j.1365-3156.2008.02031.x
4. Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic re-
view and meta-analysis. Lancet Infect Dis. 2010; 10(6):417–32. Epub 2010/06/01. S1473-3099(10)
70072-4 [pii]10.1016/S1473-3099(10)70072-4. PMID: 20510282. doi: 10.1016/S1473-3099(10)70072-4
5. Gordon MA, Graham SM, Walsh AL, Wilson L, Phiri A, Molyneux E, et al. Epidemics of invasive Salmo-
nella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multi-
drug resistance among adults and children in Malawi. Clin Infect Dis. 2008; 46(7):963–9. Epub 2008/
05/01. doi: 10.1086/529146 PMID: 18444810.
6. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med. 2002; 347
(22):1770–82. Epub 2002/11/29. doi: 10.1056/NEJMra020201347/22/1770 [pii]. PMID: 12456854.
7. Parkhill J, Dougan G, James KD, Thomson NR, Pickard D, Wain J, et al. Complete genome sequence
of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature. 2001; 413(6858):848–52.
Epub 2001/10/26. doi: 10.1038/3510160735101607 [pii]. PMID: 11677608.
8. Wain J, Hoa NT, Chinh NT, Vinh H, Everett MJ, Diep TS, et al. Quinolone-resistant Salmonella typhi in
Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis. 1997; 25
(6):1404–10. Epub 1998/02/07. PMID: 9431387.
9. Gordon MA, Walsh AL, Chaponda M, Soko D, Mbvwinji M, Molyneux ME, et al. Bacteraemia and mor-
tality among adult medical admissions in Malawi—predominance of non-typhi salmonellae and Strepto-
coccus pneumoniae. J Infect. 2001; 42(1):44–9. Epub 2001/03/13. doi: 10.1053/jinf.2000.0779S0163-
4453(00)90779-5 [pii]. PMID: 11243753.
10. Barrow G FR. Cowan and Steele’s manual for the identification of medical bacteria. Cambridge, UK:
Cambridge University Press; 1993.
11. Kauffmann F. Kauffmann-White scheme. J Hyg. 1934; 34:333–50. PMID: 20475239
12. Mtunthama N, Gordon SB, Kusimbwe T, Zijlstra EE, Molyneux ME, French N. Blood culture collection
technique and pneumococcal surveillance in Malawi during the four year period 2003–2006: an obser-
vational study. BMC Infect Dis. 2008; 8:137. Epub 2008/10/16. doi: 10.1186/1471-2334-8-137 PMID:
18854024; PubMed Central PMCID: PMC2576305.
13. BSAC. BSACmethods for antimicrobial susceptibility testing. 2013.
Epidemic Multidrug Resistant H58-S. Typhi in Malawi
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003748 April 24, 2015 11 / 13
14. Roumagnac P, Weill FX, Dolecek C, Baker S, Brisse S, Chinh NT, et al. Evolutionary history of Salmo-
nella typhi. Science. 2006; 314(5803):1301–4. Epub 2006/11/25. doi: 314/5803/1301 [pii]0.1126/sci-
ence.1134933. PMID: 17124322; PubMed Central PMCID: PMC2652035.
15. Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, Goodhead I, et al. High-throughput sequenc-
ing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet. 2008; 40
(8):987–93. Epub 2008/07/29. ng.195 [pii]10.1038/ng.195. PMID: 18660809; PubMed Central PMCID:
PMC2652037. doi: 10.1038/ng.195
16. Harris SR, Cartwright EJ, Torok ME, Holden MT, Brown NM, Ogilvy-Stuart AL, et al. Whole-genome se-
quencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study.
Lancet Infect Dis. 2013; 13(2):130–6. Epub 2012/11/20. doi: 10.1016/S1473-3099(12)70268-2 PMID:
23158674; PubMed Central PMCID: PMC3556525.
17. Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, van der Linden M, et al. Rapid pneumococcal
evolution in response to clinical interventions. Science. 2011; 331(6016):430–4. Epub 2011/01/29.
331/6016/430 [pii]10.1126/science.1198545. PMID: 21273480. doi: 10.1126/science.1198545
18. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of
taxa and mixed models. Bioinformatics. 2006; 22(21):2688–90. Epub 2006/08/25. doi: 10.1093/
bioinformatics/btl446 PMID: 16928733.
19. Sejvar J, Lutterloh E, Naiene J, Likaka A, Manda R, Nygren B, et al. Neurologic manifestations associ-
ated with an outbreak of typhoid fever, Malawi—Mozambique, 2009: an epidemiologic investigation.
PLoS One. 2012; 7(12):e46099. Epub 2012/12/12. doi: 10.1371/journal.pone.0046099 PMID:
23226492; PubMed Central PMCID: PMC3513310.
20. Feasey NA, Houston A, Mukaka M, Komrower D, Mwalukomo T, Tenthani L, et al. A reduction in adult
blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-
out. PLoS One. 2014; 9(3):e92226. Epub 2014/03/20. doi: 10.1371/journal.pone.0092226 PMID:
24643091; PubMed Central PMCID: PMC3958486.
21. Lutterloh E, Likaka A, Sejvar J, Manda R, Naiene J, Monroe SS, et al. Multidrug-resistant typhoid fever
with neurologic findings on the Malawi-Mozambique border. Clin Infect Dis. 2012; 54(8):1100–6. Epub
2012/02/24. doi: 10.1093/cid/cis012.22357702 PMID: 22357702
22. Hendriksen RS, Leekitcharoenphon P, Lukjancenko O, Lukwesa-Musyani C, Tambatamba B, Mwaba
J, et al. Genomic signature of multidrug-resistant Salmonella enterica serovar typhi isolates related to a
massive outbreak in Zambia between 2010 and 2012. J Clin Microbiol. 2015; 53(1):262–72. Epub
2014/11/14. doi: 10.1128/JCM.02026-14 PMID: 25392358; PubMed Central PMCID: PMC4290967.
23. Imanishi M, Kweza PF, Slayton RB, Urayai T, Ziro O, Mushayi W, et al. Household water treatment up-
take during a public health response to a large typhoid fever outbreak in Harare, Zimbabwe. Am J Trop
Med Hyg. 2014; 90(5):945–54. Epub 2014/03/26. doi: 10.4269/ajtmh.13-0497 PMID: 24664784;
PubMed Central PMCID: PMC4015591.
24. Neil KP, Sodha SV, Lukwago L, S OT, Mikoleit M, Simington SD, et al. A large outbreak of typhoid fever
associated with a high rate of intestinal perforation in Kasese District, Uganda, 2008–2009. Clin Infect
Dis. 2012; 54(8):1091–9. Epub 2012/02/24. doi: 10.1093/cid/cis025 PMID: 22357703.
25. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal salmonella
disease: an emerging and neglected tropical disease in Africa. Lancet. 2012; 379(9835):2489–99.
Epub 2012/05/17. doi: 10.1016/S0140-6736(11)61752-2 PMID: 22587967; PubMed Central PMCID:
PMC3402672.
26. Biggs HM, Lester R, Nadjm B, Mtove G, Todd JE, Kinabo GD, et al. Invasive Salmonella infections in
areas of high and low malaria transmission intensity in Tanzania. Clin Infect Dis. 2014; 58(5):638–47.
Epub 2013/12/18. doi: 10.1093/cid/cit798 PMID: 24336909; PubMed Central PMCID: PMC3922215.
27. Crump JA, Ramadhani HO, Morrissey AB, SagandaW, Mwako MS, Yang LY, et al. Invasive bacterial
and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in
northern Tanzania. Clin Infect Dis. 2011; 52(3):341–8. Epub 2011/01/11. ciq103 [pii]10.1093/cid/
ciq103. PMID: 21217181. doi: 10.1093/cid/ciq103
28. GasemMH, DolmansWM, Keuter MM, Djokomoeljanto RR. Poor food hygiene and housing as risk fac-
tors for typhoid fever in Semarang, Indonesia. Trop Med Int Health. 2001; 6(6):484–90. Epub 2001/06/
26. PMID: 11422963.
29. Tarr PE, Kuppens L, Jones TC, Ivanoff B, Aparin PG, Heymann DL. Considerations regarding mass
vaccination against typhoid fever as an adjunct to sanitation and public health measures: potential use
in an epidemic in Tajikistan. Am J Trop Med Hyg. 1999; 61(1):163–70. Epub 1999/08/04. PMID:
10432074.
30. Clasen T, Boisson S, Routray P, Torondel B, Bell M, Cumming O, et al. Effectiveness of a rural sanita-
tion programme on diarrhoea, soil-transmitted helminth infection, and child malnutrition in Odisha,
Epidemic Multidrug Resistant H58-S. Typhi in Malawi
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003748 April 24, 2015 12 / 13
India: a cluster-randomised trial. Lancet Glob Health. 2014; 2(11):e645–53. Epub 2014/12/03. doi: 10.
1016/S2214-109X(14)70307-9 PMID: 25442689.
31. Kumwenda S TM, Kalulu K., Kamabala C. Determination of Physical and Chemical pollutants in Mudi
River in Malawi Journal of Basic and Applied Scientific Research. 2012; 2(7):6833–9.
32. Kumwenda CM S., KadewaW., Ngwira B. and Morse T.. Is manure from ecological sanitation latrines
safe for use as fertilizer in agricultural fields? A review of evidence from literature. 2014 37th WEDC In-
ternational Conference; Hanoi, Vietnam.
33. Manda MAZ. Water and sanitation in urban Malawi: Can the Millennium Development Goals be met? A
study of informal settlements in three cities International Institute for Environment and Development
2009.
34. Office for National Statistics, Malawi. Malawi Population Projections 1998–2023. 2012 Zomba, Malawi.
PMID: 12870616
35. Parry CM, Thuy CT, Dongol S, Karkey A, Vinh H, Chinh NT, et al. Suitable disk antimicrobial suscepti-
bility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluo-
roquinolones. Antimicrob Agents Chemother. 2010; 54(12):5201–8. Epub 2010/09/15. doi: 10.1128/
AAC.00963-10 PMID: 20837759; PubMed Central PMCID: PMC2981260.
Epidemic Multidrug Resistant H58-S. Typhi in Malawi
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003748 April 24, 2015 13 / 13
